Interpretation on Regulation and Policy for “Three Schemes ”of China Food and Drug Administration(CFDA)
Room 2006 , Moma Towers, Chaoyang North Street, 199,
Chaoyang District, 100026,Beijing, China
Abstract
China’s State Food and Drug Administration (SFDA) has issued “Three Schemes ” (Main Responsibilities, Internal Structure and Staffing) after it changed name to China Food and Drug Administration (CFDA), which arouses conjectures among industry insiders, especially on the issues that imported non-special use cosmetics must apply for record-keeping to the food and drug administrations at provincial level, however, the detailed laws and regulations on the issue have not been released in China. The article covers policy interpretation, as well as analysis of CFDA’s and regulations on children cosmetics declaration, non-special usage cosmetics classification, and existing cosmetics ingredients.
INTRODUCTION
After issuing “Three Schemes ”, great expectation has been placed on CFDA, and the new reforms on food regulatory changes in sub-sub-issues, drug regulatory decentralization, strengthen macroeconomic policies and local supervision have been significantly attended by the industry.
One of the options for the current round of institutional reform, Market Supervisory Authority is established with reference to the practice of Guangdong, Shenzhen, Shunde, health products placed under a unified framework for risk analysis of consolidated supervision. But there exist some doubts in plans implement, and the drug administrations at provincial level have not published detailed policies. The policies about cosmetics in the “Three Schemes” are listed below:
- The procedures of examination and approval required for manufacture of cosmetics and grant of hygiene certificate will be combined into a single examination and approval procedure;
- The food and drug administrations at provincial level take the responsibilities of the original SFDA for examination and approval of import of non-special function cosmetics; ... ...